Nexalin Technology (NXL)

• Market cap: $26.4M
• 1 day: 0.69%
• 5 days: -14.2%
• 1 month: 52.63%
• 3 months: 28.32%
• 6 months: -20.33%
• Year to date: -54.83%
• 1 year: -34.09%
• 5 years: -35.56%
• 10 years: -35.56%
• Sector: Healthcare
• Industry: Medical Devices

About: Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Employees: 7